Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pyxant Labs Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10913
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharmacokinetic or pharmacodynamic studies. It also provides metabolism and toxicology bioanalytical support, pharmaceutical and bioequivalence support, medication management, GLP bioanalysis, and others. The laboratory offers bioanalytical services for the assay of RNA therapeutics and hybridization assays platforms, and regulatory development studies for serum, plasma and various tissues. Pyxant is headquartered in Colorado Springs, Colorado, the US.

Pyxant Labs Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Pyxant Labs Raises Additional USD0.1 Million Financing 9
Pyxant Labs Raises USD0.4 Million in Venture Financing 10
Pyxant Labs Raises USD0.7 Million in Financing Round 11
Pyxant Labs Inc – Key Competitors 12
Pyxant Labs Inc – Key Employees 13
Pyxant Labs Inc – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Pyxant Labs Raises Additional USD0.1 Million Financing 9
Pyxant Labs Raises USD0.4 Million in Venture Financing 10
Pyxant Labs Raises USD0.7 Million in Financing Round 11
Pyxant Labs Inc, Key Competitors 12
Pyxant Labs Inc, Key Employees 13

List of Figures
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vipul Ltd.:戦略・SWOT・企業財務分析
    Vipul Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vipul Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tellabs, Inc.:企業の戦略的SWOT分析
    Tellabs, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Epinex Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Epinex Diagnostics Inc (Epinex) is a medical device company that offers rapid diagnostic tests. The company’s products comprise point-of-care test device and over-the-counter test device. Its Epinex G1A system is rapid diabetes monitoring index test for the control of glycation. Epinex offer …
  • Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatmen …
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nano-Terra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nano-Terra Inc (Nano-Terra) is a clean technology company that develops and commercializes nano technology products. The company’s products include coating, advanced materials, organic and inorganic molecules, materials, polymers and UV water filtration system. It provides surface science, c …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務情報
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Teladoc Health Inc (TDOC):企業の財務・戦略的SWOT分析
    Summary Teladoc Health Inc (Teladoc Health), formerly TelaDoc Inc, is a provider of virtual healthcare services for wellness and prevention of acute care and complex healthcare needs. It offers primary care services managing chronic conditions; mental health guidance; personalized digital healthcare …
  • Kyivstar JSC:企業の戦略的SWOT分析
    Kyivstar JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • DHL Supply Chain (formerly Exel Inc.):戦略・SWOT・企業財務分析
    DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • SRS Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables products c …
  • Sernova Corp (SVA):企業の財務・戦略的SWOT分析
    Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ono Pharmaceutical Co Ltd (4528)-医療機器分野:企業M&A・提携分析
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of diseases such as type I …
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Scheid Vineyards Inc:企業の戦略・SWOT・財務情報
    Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report Summary Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PartnerRe Ltd.:戦略・SWOT・企業財務分析
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CJ Foodville Corporation:企業の戦略・SWOT・財務分析
    CJ Foodville Corporation - Strategy, SWOT and Corporate Finance Report Summary CJ Foodville Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆